IHAM
Integral Health Asset Management’s Cytokinetics CYTK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33M | Sell |
1,000,000
-100,000
| -9% | -$3.3M | 3.02% | 6 |
|
|
2025
Q1 | $44.2M | Buy |
1,100,000
+100,000
| +10% | +$4.02M | 4.7% | 3 |
|
|
2024
Q4 | $47M | Buy |
1,000,000
+250,000
| +33% | +$11.8M | 4.01% | 5 |
|
|
2024
Q3 | $39.6M | Sell |
750,000
-250,000
| -25% | -$13.2M | 4.46% | 4 |
|
|
2024
Q2 | $54.2M | Buy |
1,000,000
+550,000
| +122% | +$29.8M | 5.15% | 3 |
|
|
2024
Q1 | $31.5M | Buy |
450,000
+250,000
| +125% | +$17.5M | 2.93% | 5 |
|
|
2023
Q4 | $16.7M | Sell |
200,000
-600,000
| -75% | -$50.1M | 2.27% | 9 |
|
|
2023
Q3 | $23.6M | Buy |
800,000
+150,000
| +23% | +$4.42M | 3.26% | 5 |
|
|
2023
Q2 | $21.2M | Buy |
650,000
+50,000
| +8% | +$1.63M | 2.63% | 6 |
|
|
2023
Q1 | $21.1M | Buy |
600,000
+200,000
| +50% | +$7.04M | 4.25% | 2 |
|
|
2022
Q4 | $18.3M | Buy |
400,000
+50,000
| +14% | +$2.29M | 3.85% | 1 |
|
|
2022
Q3 | $17M | Sell |
350,000
-175,000
| -33% | -$8.48M | 3.29% | 4 |
|
|
2022
Q2 | $20.6M | Buy |
525,000
+55,000
| +12% | +$2.16M | 4.24% | 4 |
|
|
2022
Q1 | $17.3M | Buy |
470,000
+145,000
| +45% | +$5.34M | 4.5% | 2 |
|
|
2021
Q4 | $14.8M | Hold |
325,000
| – | – | 4.1% | 3 |
|
|
2021
Q3 | $11.6M | Sell |
325,000
-375,000
| -54% | -$13.4M | 3.34% | 5 |
|
|
2021
Q2 | $13.9M | Hold |
700,000
| – | – | 3.81% | 4 |
|
|
2021
Q1 | $16.3M | Buy |
700,000
+175,000
| +33% | +$4.07M | 4.65% | 2 |
|
|
2020
Q4 | $10.9M | Buy |
525,000
+325,000
| +163% | +$6.75M | 3.25% | 8 |
|
|
2020
Q3 | $4.33M | Sell |
200,000
-140,000
| -41% | -$3.03M | 1.32% | 25 |
|
|
2020
Q2 | $8.01M | Buy |
340,000
+20,000
| +6% | +$471K | 2.4% | 14 |
|
|
2020
Q1 | $3.77M | Buy |
+320,000
| New | +$3.77M | 1.66% | 24 |
|